Contact
searchSearch
HMP Global

Volume 24 - Issue 5 - May 2016

Spotlight
Spotlight on: Charles E. Crutchfield III, MD
06/16/2016
Benjamin Barankin, MD, FRCPC
Charles E. Crutchfield III, MD, is a clinical professor of dermatology at the University of Minnesota Medical School.
Charles E. Crutchfield III, MD, is a clinical professor of dermatology at the University of Minnesota Medical School.
Charles E. Crutchfield III, MD,...
06/16/2016
The Dermatologist
Research in Review
Treating Submental Fat
06/14/2016
Kenneth Beer, MD
One year after its approval, Dr Beer provides an update on clinical experience with deoxycholic acid (Kybella).
One year after its approval, Dr Beer provides an update on clinical experience with deoxycholic acid (Kybella).
One year after its approval, Dr...
06/14/2016
The Dermatologist
Voices
What`s Ahead for the Skin Cancer Foundation?
06/13/2016
Dan Latore
The Skin Cancer Foundation is poised for growth. New initiatives help reduce the incidence and mortality of the disease. 
The Skin Cancer Foundation is poised for growth. New initiatives help reduce the incidence and mortality of the disease. 
The Skin Cancer Foundation is...
06/13/2016
The Dermatologist
News
Study: Discontinuing Treatment With Nivolumab Does Not Affect Survival in Patients With Melanoma
06/13/2016
Discontinuing nivolumab-ipilimumab treatment because of adverse events may not have a detrimental impact on survival among patients with advanced melanoma, according to follow-up from a randomized trial presented at the American Society of...
Discontinuing nivolumab-ipilimumab treatment because of adverse events may not have a detrimental impact on survival among patients with advanced melanoma, according to follow-up from a randomized trial presented at the American Society of...
Discontinuing...
06/13/2016
The Dermatologist
The Dermatopathologist
Squamoid Eccrine Ductal Carcinoma
06/13/2016
Cynthia M. Magro, MD
This case study presents an unusual case of a low-grade eccrine carcinoma showing squamous differentiation. 
This case study presents an unusual case of a low-grade eccrine carcinoma showing squamous differentiation. 
This case study presents an...
06/13/2016
The Dermatologist
News
Study: Biologic Demonstrates Long-term Efficacy for Plaque Psoriasis
06/10/2016
Results from 3 Phase 3 studies, published in The New England Journal of Medicine, demonstrated the safety and efficacy of ixekizumab (Taltz) for the treatment of moderate to severe plaque psoriasis.
Results from 3 Phase 3 studies, published in The New England Journal of Medicine, demonstrated the safety and efficacy of ixekizumab (Taltz) for the treatment of moderate to severe plaque psoriasis.
Results from 3 Phase 3 studies,...
06/10/2016
The Dermatologist
News
Second Phase 3 Tofacitinib Trial Results for PsA
06/09/2016
Positive, top-line results from the second Phase 3 Oral Psoriatic Arthritis Trial (OPAL) Beyond study of tofacitinib citrate (Xeljanz) were recently released.
Positive, top-line results from the second Phase 3 Oral Psoriatic Arthritis Trial (OPAL) Beyond study of tofacitinib citrate (Xeljanz) were recently released.
Positive, top-line results from...
06/09/2016
The Dermatologist
Research in Review
Update on Isothiazolinones
06/08/2016
Sharon E. Jabob, MD; Misha Bertolino, MA; Michael Lipp, DO; Alina Goldenberg, BA, MAS, MD
Isothiazolinones are synthetic biocides/preservatives found in many skin and hair products and industrial products.
Isothiazolinones are synthetic biocides/preservatives found in many skin and hair products and industrial products.
Isothiazolinones are synthetic...
06/08/2016
The Dermatologist
News
Early Results: Combination Pembrolizumab Effective for Melanoma Treatment
06/07/2016
Positive early results from 3 studies using anti-PD-1 therapy pembrolizumab (Keytruda) in combination with various other treatments for advanced melanoma were presented at the 2016 American Society of Clinical Oncology (ASCO) in...
Positive early results from 3 studies using anti-PD-1 therapy pembrolizumab (Keytruda) in combination with various other treatments for advanced melanoma were presented at the 2016 American Society of Clinical Oncology (ASCO) in...
Positive early results from 3...
06/07/2016
The Dermatologist
Update on Wound Care: Epidermal Grafting
06/07/2016
Lam Le, MD; Mark Shaw, DO, FACEP; Lee C. Rogers, DPM, FFPM RCPS; Paul Liu, MD; Katherine Lincoln, DO; Animesh Bhatia, DPM, CWS; John C. Lantis, II, MD, FACS; Brent Bernstein, DPM; David Young, MD; Robert S. Kirsner, MD, PhD
This article provides an overview of epidermal grafting and its potential roles in wound care and closure. Cases demonstrating the successful use of epidermal skin grafts over various wound types are also included.
This article provides an overview of epidermal grafting and its potential roles in wound care and closure. Cases demonstrating the successful use of epidermal skin grafts over various wound types are also included.
This article provides an...
06/07/2016
The Dermatologist
News
Q. Can you name four common co-morbidities of psoriasis?
06/02/2016
Click here to see the answer. 
Click here to see the answer. 
Click here to see the...
06/02/2016
The Dermatologist
Derm Dx
What Is This Hair Change on the Scalp?
06/02/2016
David M. Lemchak; Oleg E. Akilov, MD, PhD
A 64-year-old man presented for management of his chronic skin condition on the scalp.
A 64-year-old man presented for management of his chronic skin condition on the scalp.
A 64-year-old man presented for...
06/02/2016
The Dermatologist
A Look At The Latest Skin Cancer Research
06/02/2016
Lisa B. Samalonis
This review looks at new research results and trends in therapies for skin cancer. 
This review looks at new research results and trends in therapies for skin cancer. 
This review looks at new...
06/02/2016
The Dermatologist
Injectable Receives FDA Approval
06/01/2016
Juvéderm Volbella XC (Allergan) received FDA approval for use in the lips for lip augmentation and for correction of perioral rhytids, or perioral lines, in adults over the age of 21.
Juvéderm Volbella XC (Allergan) received FDA approval for use in the lips for lip augmentation and for correction of perioral rhytids, or perioral lines, in adults over the age of 21.
Juvéderm Volbella XC (Allergan)...
06/01/2016
The Dermatologist
Pfizer to Buy Anacor
05/31/2016
Pfizer Inc. and Anacor Pharmaceuticals, Inc. have entered into a definitive merger agreement under which Pfizer will acquire Anacor.
Pfizer Inc. and Anacor Pharmaceuticals, Inc. have entered into a definitive merger agreement under which Pfizer will acquire Anacor.
Pfizer Inc. and Anacor...
05/31/2016
The Dermatologist
News
Q. How many people in the United States have psoriasis? In what patient population is it most prevalent?
05/28/2016
Click here to see the answer.
Click here to see the answer.
Click here to see the answer.
05/28/2016
The Dermatologist
FDA Alerts
Analyst: New Psoriasis Biologic Could Be Blockbuster
05/27/2016
A recently-approved plaque psoriasis drug is predicted to generate sales more than $1 billion in the US and Europe. 
A recently-approved plaque psoriasis drug is predicted to generate sales more than $1 billion in the US and Europe. 
A recently-approved plaque...
05/27/2016
The Dermatologist
News
Is Overall Drug Utilization Increased in Patients with Psoriasis?
05/26/2016
A recent study evaluated detailed drug utilization in patients with psoriasis compared with controls in a population-based sample.
A recent study evaluated detailed drug utilization in patients with psoriasis compared with controls in a population-based sample.
A recent study evaluated...
05/26/2016
The Dermatologist
Board Review
The Dermatologist’s Board Review - May
05/24/2016
Ron J. Feldman, MD, PhD; Jo-David Fine, MD, MPH, FRCP
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to www.pre-board.com. The program will be available from April 15, 2016 to November 15, 2016....
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to www.pre-board.com. The program will be available from April 15, 2016 to November 15, 2016....
The contents of these questions...
05/24/2016
The Dermatologist
Therapeutic Review
Research Highlights on Atopic Dermatitis
05/24/2016
Lisa B. Samalonis
Posters included recent research covering a variety of aspects of atopic dermatitis.  
Posters included recent research covering a variety of aspects of atopic dermatitis.  
Posters included recent research...
05/24/2016
The Dermatologist
SDPA Feature
Advocacy and Education Is Crucial to PA Profession
05/24/2016
Jennifer Winter, MSPAS, PA-C
PAs have a responsibility to advocate for their profession. This article offers recommendations on how PAs can get involved at the local, state, and national levels.   
PAs have a responsibility to advocate for their profession. This article offers recommendations on how PAs can get involved at the local, state, and national levels.   
PAs have a responsibility to...
05/24/2016
The Dermatologist
News
New Barrier Repair Cream for Eczema/Atopic Dermatitis
05/23/2016
IntraDerm Pharmaceuticals’ Ceramax skin barrier cream recently received FDA clearance as a topical skincare preparation to relieve and to manage the burning and itching associated with various dermatoses.
IntraDerm Pharmaceuticals’ Ceramax skin barrier cream recently received FDA clearance as a topical skincare preparation to relieve and to manage the burning and itching associated with various dermatoses.
IntraDerm Pharmaceuticals’...
05/23/2016
The Dermatologist
Chief Medical Editor Message
The Powerful Tool of Inertia
05/23/2016
Steven R. Feldman, MD, PhD
In recent years, the field of economics has been invigorated with the work of experimental behavioral psychologists.
In recent years, the field of economics has been invigorated with the work of experimental behavioral psychologists.
In recent years, the field of...
05/23/2016
The Dermatologist
Research in Review
Is ‘Complete Skin Clearance’ in Psoriasis a Clinically Meaningful Endpoint?
05/23/2016
New psoriasis therapies have increased the ability for patients to achieve skin clearance. However, more evidence is needed on the impact of total skin clearance from the patient perspective. Researchers set out to determine if complete skin...
New psoriasis therapies have increased the ability for patients to achieve skin clearance. However, more evidence is needed on the impact of total skin clearance from the patient perspective. Researchers set out to determine if complete skin...
New psoriasis therapies have...
05/23/2016
The Dermatologist
News
OLE Study: Biologic Safe and Effective for Pediatric Psoriasis
05/23/2016
The open-label extension (OLE) study evaluated the long-term safety and efficacy of etanercept (Enbrel) for pediatric psoriasis. 
The open-label extension (OLE) study evaluated the long-term safety and efficacy of etanercept (Enbrel) for pediatric psoriasis. 
The open-label extension (OLE)...
05/23/2016
The Dermatologist
News
Registry to Track Safety of New Biologic Treatment
05/20/2016
The Corrona Psoriasis Registry will track the drug safety reporting for ixekizumab (Taltz), a new biologic medication by Eli Lilly and Company that was recently FDA approved for the treatment of moderate to severe plaque psoriasis.
The Corrona Psoriasis Registry will track the drug safety reporting for ixekizumab (Taltz), a new biologic medication by Eli Lilly and Company that was recently FDA approved for the treatment of moderate to severe plaque psoriasis.
The Corrona Psoriasis Registry...
05/20/2016
The Dermatologist

Popular Articles

Board Review
The Dermatologist’s Board Review - January/February 2024
02/08/2024
Amy J. McMichael, MD
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to https://www.galderma.com/us/preboard-webinar.
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to https://www.galderma.com/us/preboard-webinar.
The contents of these questions...
02/08/2024
The Dermatologist
skin cancer
News
Regulatory T Cell Involvement in Melanoma Prognosis and Treatment Strategy
03/28/2024
Jessica Garlewicz
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell RNA sequencing data alongside clinical information.
Researchers analyzed single-cell...
03/28/2024
The Dermatologist
acne
News
Acne’s Impact on Life-Changing Decisions Among Young Adults
05/06/2024
Jessica Garlewicz
Researchers aimed to evaluate the influence of acne on major life-changing decisions in young adults.
Researchers aimed to evaluate the influence of acne on major life-changing decisions in young adults.
Researchers aimed to evaluate...
05/06/2024
The Dermatologist
NAAF-Reviewed Content
Improving Lives With Alopecia Areata Treatment
06/06/2024
Riya Gandhi, MA
Dr Arash Mostaghimi discusses innovative approaches for meaningful hair regrowth and the role of patient advocacy in supporting those affected by this autoimmune disease.
Dr Arash Mostaghimi discusses innovative approaches for meaningful hair regrowth and the role of patient advocacy in supporting those affected by this autoimmune disease.
Dr Arash Mostaghimi discusses...
06/06/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
Riya Gandhi, MA
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
jan/feb issue

Current Issue

January 2026
Volume 34
Issue 1
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
Quiz
Why Higher JAK Doses Raise Safety Concerns in AD
01/01/2026
Riya Gandhi, MA
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can...
01/01/2026
The Dermatologist
Quiz
What Drives Fibrosis in Chronic Atopic Dermatitis Lesions?
01/01/2026
Riya Gandhi, MA
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how...
01/01/2026
The Dermatologist
Quiz
Alopecia Areata Support Systems, Peer Networks, and Patient Misinformation
12/20/2025
Riya Gandhi, MA
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients...
12/20/2025
The Dermatologist
acne
Quiz
Quiz: Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
psoriasis
Quiz
Quiz: Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
Quiz
Etiological Communication, Atopy, and First-Visit Navigation in AA
12/10/2025
Riya Gandhi, MA
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit...
12/10/2025
The Dermatologist
Quiz
Clinical Benefit of Accurate Risk Stratification in cSCC Management
12/04/2025
Jessica Garlewicz
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical...
12/04/2025
The Dermatologist
Quiz
Investigative Urgency and Autoimmune Framing in AA
12/01/2025
Riya Gandhi, MA
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive...
12/01/2025
The Dermatologist

May 2016 Issue 5

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use